Skip to main content

Ikarian Capital, LLC

Position in MAZE — Maze Therapeutics, Inc.

CIK 1778253 DALLAS, TX

Position in MAZE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,309,330
-$3,790 QoQ
Shares Held
378,999
0.0% QoQ
Ownership
0.682%
of shares outstanding
% of Portfolio
1.83%
of 13F equity value
Holder Rank
#31
of 161 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MAZE Over Time

Shares Held

Position Value (USD)

Derivatives in MAZE

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$429,840
PutShares
14,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. MAZE ranks #15 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MAZE

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,309,330 378,999
2026-03-31 $11,313,120 378,999
2026-03-31 $429,840 14,400
2025-12-31 $26,709,092 644,680
2025-09-30 $19,209,592 740,825
2025-06-30 $3,223,819 262,740
2025-03-31 $3,553,367 322,740